Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News

13:04 EST 14th November 2018 | BioPortfolio

Showing News Articles 1–25 of 440,000+

Wednesday 14th November 2018

Humana Medicare Advantage Plan Addresses High Fall Rates Among Older Adults in St. Louis

MA Plan influenced by Washington University research through the Home Hazard Removal Program (HARP) that addresses home hazards for aging St. Louisans Humana Inc. (NYSE: HUM) is offering a Medicare Advantage plan in St. Louis with a fall prevention benefit. The benefit is administered by Washington University in conjunction with

Zelis® Healthcare Ranks Among New Jersey’s Fastest-Growing Companies

Company’s Growth Continues, Makes Fast 50 List Again Zelis Healthcare, a healthcare technology company and market-leading provider of integrated healthcare cost management and payments solutions, has been named one of New Jersey’s 50 fastest-growing companies once again. At the 2018 Fast 50 awards re

MannKind Corp MNKD Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryMannKind Corp MannKind is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapidaction inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. The product consists of a dry powder formulation...

Tales from the crypt: new insights into intestinal stem cells

Virbac: Availability of the quarterly financial information as of September 30, 2018

Virbac: Availability of the quarterly financial information as of September 30, 2018 Public release - November 14, 2018 The quarterly financial information as of September 30, 2018 is available: ·           on our website: corporate.virbac.com under the section Investors - Financial reports - 2018;·           or on request, under legal and regulatory conditions. ...

Pfizer Inc PFE Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryPfizer Inc Pfizer is a biopharmaceutical company, which discovers, develops, manufactures and markets healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products to treat various conditions including infection, cancer, inflammation, immune disorders and rare diseases, besides vaccines. It also provides sterile injectable pharmaceutica...

KLF2 regulates osteoblast differentiation by targeting of Runx2

Can electronic health records revive central nervous system clinical trials?

Pairwise Establishes Durham, N.C., Headquarters to Lead Innovation in Food and Agriculture

Location at Golden Belt Campus positions company in the heart of life sciences hub Pairwise today announced it has selected Durham, N.C., as its headquarters and will lease space on the Golden Belt Campus in the heart of downtown. The move represents a commitment to growth in a region ripe with innovation and engagement in the agricultural techn...

Women With Diabetes Can Control Vaginal Health, According to Mache Seibel, M.D.

With approximately 9.7 million women in the U.S. suffering with diabetes and almost 50 million U.S. adults with prediabetes, most of the women are experiencing uncomfortable vaginal symptoms like recurrent yeast and bacterial infections, vaginal dryness, reduced sexual interest, and painful intercourse that can adversely affect quality of life. ...

Effects of a low carbohydrate diet on energy expenditure during weight loss maintenance: randomized trial

AbstractObjectiveTo determine the effects of diets varying in carbohydrate to fat ratio on total energy expenditure.DesignRandomized trial.SettingMulticenter collaboration at US two sites, August...

Braced for Brexit

Blood and insulin: a cold storage catastrophe?—Nigel Hawkes and Jacqui WiseIf the UK leaves the European Union without a deal in place, supplies of drugs could face “a catastrophic time,” according...

An unusual cause of right iliac fossa pain

A 34 year old woman presented to the emergency department with a history of worsening right iliac fossa pain over several days. She described the pain as alternating dull and sharp, and had found...

Anticoagulants after arthroplasty . . . and other stories

Preventing venous thromboembolism after arthroplastyVenous thromboembolism is a well recognised risk after knee arthroplasty, but there’s no consensus on the best prophylaxis. A large retrospective...

Lidds AB LIDDS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryLidds AB Lidds is a developer of pharmaceutical products for the treatment of cancer and other diseases. The company offers Liproca Depot, an injectable product used for the treatment of prostate cancer. Its Liproca is a bioresorbable, biocompatible and locally injectable modified release formulation of 2hydroxyflutamid that is prepared as a paste prior to injection. Lidds' develops efficie...

Medac Partners with Medaxion® to Provide Seamless Billing Integration to Providers

Today Medac, Inc. announced a partnership with Medaxion to provide seamless billing integration to providers. The technical integration between Medac and Medaxion’s cloud-connected anesthesia information management system (AIMS) will enhance the efficiency of charge and operational data flows for Medac practices. Medaxion’s innovative, user-centric app...

Discovery Could Lead to Smaller, Cheaper IoT Sensors

NewsNovel picoWatt-power wake-up timer cuts minimum power consumption of IoT sensor nodes by 1,000 times.Contributed Author: 

Athenex Announces Third Quarter 2018 Financial Results and Provides Corporate Update

Athenex (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced its financial results and business highlights for the three- and nine-months ended September 30, 2018. As quoted in the press release: “We achieved continued positive momentum at Athenex in &...

Axsome Therapeutics Announces Completion of Patient Enrollment in the ASCEND Phase 2 Trial of AXS-05 in Major Depressive Disorder

Axsome Therapeutics (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced the completion of patient enrollment in the ASCEND (Assessing Clinical Episodes in Depression) study, a Phase 2 randomized, controlled trial of AXS-05 in major depressive disorder (MDD). As quoted in the press release...

Brighter Way Institute Awarded $250,000 From The Bob & Renee Parsons Foundation

Institute Provides Comprehensive Dental Care to Underserved Communities PHOENIX, Ariz. (PRWEB) November 14, 2018 Brighter Way Institute has been awarded a $250,000 grant from The Bob & Renee Parsons Foundation to help fund staffing needs for its three dental centers. The expanded staff will allow the Institute to provide care to an additional 3,000 patients over the next 12 months. Through co...

French pharma group Ipsen closes in on its next drug deals https://reut.rs/2QN3ZiQ 

French pharma group Ipsen closes in on its next drug deals https://reut.rs/2QN3ZiQ 

Inside the Biotech Lab and Image Gallery

ISAAA releases its latest addition to the Biotech Communication Series, Inside the Biotech Lab: How to Genetically Engineer a Plant? which is a visual documentation of how scientists conduct genetic transformation in the laboratory. Together with the new publication, ISAAA also releases the ISAAA Biotech/GM Crops Image Gallery which contains over 1...

UC Davis European Plant Breeding Academy Class 6 Now Open for Registration

University of California, Davis Plant Breeding Academy (PBA) is a professional certificate program offered since 2006 with classes in USA, Europe, Africa, and Asia. To date, the program has trained nearly 300 breeders, 80% of which are from the private seed industry. Class 6 of the European PBA will start in October 2019 and it is now open for regi...

Industrial Biotechnology and Bioenergy Networks to Facilitate Shift to Low Carbon Economy

The Biotechnology and Biological Sciences Research Council (BBSRC), together with the Engineering and Physical Sciences Research Council (EPSRC) have committed to fund six unique collaborative Networks in Industrial Biotechnology and Bioenergy (BBSRC NIBB) to support, encourage, and facilitate the shift to a low carbon economy from using fossil res...

Researchers Identify the Best-Performing Cas Nuclease

CRISPR-mediated genome editing has been applied in several plants using several types of Cas nucleases. However, these nucleases have not been directly compared with each other to determine which enzyme is best performing in terms of efficiency and specificity. Thus, researcher Nicola Patron from Earlham Institute in the United Kingdom and colleagu...


Advertisement
Quick Search
Advertisement
Advertisement

 

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.